Kwality Pharmaceuticals Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 919.77 million compared to INR 688.04 million a year ago. Revenue was INR 925.6 million compared to INR 702.64 million a year ago.

Net income was INR 43.64 million compared to net loss of INR 73.79 million a year ago. Basic earnings per share from continuing operations was INR 4.08 compared to basic loss per share from continuing operations of INR 7.23 a year ago. Diluted earnings per share from continuing operations was INR 4.08 compared to diluted loss per share from continuing operations of INR 7.23 a year ago.